BIOA Stock Analysis: Buy, Sell, or Hold?
BIOA - BioAge Labs, Inc. Common Stock
$10.78
1.74 (19.25%)
β²
5d:
-48.37%
30d:
-57.05%
90d:
-35.8%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
TODAY
Get Alerted When BIOA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: BIOA is down 48.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: BIOA is down 48.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIOA is currently trading at $10.78, which is considered oversold relative to its 30-day fair value range of $18.52 to $25.91.
Technical Outlook: Technically, BIOA is in a uptrend. Immediate support is located at $8.65, while resistance sits at $24.91. The stock is showing strong short-term momentum, up 19.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.88 (+269.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOA is in a uptrend. Immediate support is located at $8.65, while resistance sits at $24.91. The stock is showing strong short-term momentum, up 19.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.88 (+269.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.52 -
$25.91
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Protect Your Profits
Holding BIOA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+19.2%)
- BULLISH: Trading 269.9% below Wall St target ($39.88)
- WARNING: Recommendation downgraded due to -48.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$18.52 -
$25.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.65
Resistance Level
$24.91
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.41
Wall Street Target
$39.88
(+269.9%)
Revenue Growth (YoY)
91.0%
Share & Embed Analysis
Last updated: August 03, 2026 7:58 PM ET
Data refreshes hourly during market hours. Next update: 8:58 PM
Data refreshes hourly during market hours. Next update: 8:58 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I⦠|
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp⦠|
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P⦠|
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced BIOA Option Strategies
Professional options setups generated by AI based on today's BIOA price and gamma walls.